<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIMS/HYPOTHESIS: <z:hpo ids='HP_0000855'>Insulin resistance</z:hpo> and type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> are associated with <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> dysfunction </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of the present study was to test the hypothesis that oxidative phosphorylation and electron transport capacity are diminished in the skeletal muscle of type 2 diabetic subjects, as a result of a reduction in the <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> content </plain></SENT>
<SENT sid="2" pm="."><plain>MATERIALS AND METHODS: The <z:chebi fb="0" ids="15379">O(2)</z:chebi> flux capacity of permeabilised muscle fibres from biopsies of the quadriceps in healthy subjects (n = 8; age 58 +/- 2 years [mean+/-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SEM</z:e>]; BMI 28 +/- 1 kg/m(2); fasting plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> 5.4 +/- 0.2 mmol/l) and patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (n = 11; age 62 +/- 2 years; BMI 32 +/- 2 kg/m(2); fasting plasma <z:chebi fb="105" ids="17234">glucose</z:chebi> 9.0 +/- 0.8 mmol/l) was measured by high-resolution respirometry </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: <z:chebi fb="0" ids="15379">O(2)</z:chebi> flux expressed per mg of muscle (fresh weight) during <z:chebi fb="13" ids="16761">ADP</z:chebi>-stimulated state 3 respiration was lower (p &lt; 0.05) in patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> in the presence of complex I substrate (<z:chebi fb="6" ids="14321,29987">glutamate</z:chebi>) (31 +/- 2 vs 43 +/- 3 pmol <z:chebi fb="0" ids="15379">O(2)</z:chebi> s(-1) mg(-1)) and in response to <z:chebi fb="6" ids="14321,29987">glutamate</z:chebi> + succinate (parallel electron input from complexes I and II) (63 +/- 3 vs 85 +/- 6 pmol s(-1) mg(-1)) </plain></SENT>
<SENT sid="4" pm="."><plain>Further increases in <z:chebi fb="0" ids="15379">O(2)</z:chebi> flux capacity were observed in response to uncoupling by FCCP, but were again lower (p &lt; 0.05) in type 2 diabetic patients than in healthy control subjects (86 +/- 4 vs 109 +/- 8 pmol s(-1) mg(-1)) </plain></SENT>
<SENT sid="5" pm="."><plain>However, when <z:chebi fb="0" ids="15379">O(2)</z:chebi> flux was normalised for <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> DNA content or <z:chebi fb="2" ids="50744">citrate</z:chebi> synthase activity, there were no differences in oxidative phosphorylation or electron transport capacity between patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> and healthy control subjects </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS/INTERPRETATION: <z:hpo ids='HP_0001427'>Mitochondrial</z:hpo> function is <z:mpath ids='MPATH_458'>normal</z:mpath> in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="7" pm="."><plain>Blunting of coupled and uncoupled respiration in type 2 diabetic patients can be attributed to lower <z:hpo ids='HP_0001427'>mitochondrial</z:hpo> content </plain></SENT>
</text></document>